dengue
Takeda: Dengue vaccine successful in long-term trials & set for global distribution
May 25, 2021Manufacturing and Production EMA, Vaccine, dengue
Japanese pharma company Takeda has announced long-term safety and efficacy results for its dengue vaccine candidate, TAK-003, and has successfully …
Strong Phase 3 showing for Takeda’s dengue vaccine, but concerns remain over consistent coverage
November 7, 2019Research and Development Takeda, dengue, pharma
Takeda has unveiled new data from its ongoing Phase 3 trial investigating the efficacy of its vaccine candidate TAK-003 in …
Sanofi’s Dengvaxia becomes first FDA-approved dengue vaccine, but with caveats…
May 2, 2019Sales and Marketing FDA, Sanofi, dengue, dengvaxia, pharma
Sanofi has announced that the FDA has granted authorisation to its tetravalent vaccine Dengvaxia for prevention of dengue disease originating …
FDA advisory panel recommends Sanofi’s dengue vaccine in children, but rejects its use in adults
March 11, 2019Sales and Marketing FDA, Sanofi, US, Vaccine, dengue, dengvaxia, pharma
Dengvaxia, Sanofi’s vaccine for dengue fever, has been burdened with further negative scrutiny after the FDA’s vaccine advisory panel passed …
Philippines Department of Justice recommends charges against six Sanofi officials
March 1, 2019Medical Communications Philippines, Sanofi, dengue, dengvaxia, vaccines
The Philippine Justice Ministry has said it has found probably cause to charge officials working for French drugmaker Sanofi over …
Philippines’ FDA halts sales of Sanofi’s dengue vaccine
February 19, 2019Manufacturing and Production, Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma
The marketing authorisation for Sanofi’s dengue vaccine Dengvaxia has been revoked in the Philippines after the country’s Food and Drug …
Diet drugs supress appetite in mosquitoes, study shows
February 11, 2019Sales and Marketing Zika, dengue, infectuous diseases, malaria, mosquitoes
Scientists were able to supress mosquitoes appetites using diet drugs for humans, according to research published in the journal Cell. …
Takeda’s dengue vaccine proves efficacious in massive Phase 3 trial
January 30, 2019Research and Development Dengue fever, TAK-003, Takeda, Vaccine, dengue, health, infectious diseases
Takeda’s dengue vaccine candidate TAK-003, has proved efficacious in preventing dengue fever in healthy children and adolescents in an ongoing …
Danger of Sanofi’s dengue vaccine confirmed in new study
June 14, 2018Medical Communications, Research and Development Sanofi, biotech, dengue, dengvaxia, drugs, pharma, pharmaceutical
A study that thoroughly analyses the impact of Sanofi’s dengue vaccine has confirmed what was feared – children without prior …
Sanofi’s controversial dengue vaccine may still hit US market, despite Philippines disaster
March 7, 2018Sales and Marketing FDA, Philippines, Sanofi, US, dengue, dengvaxia, pharma
Sanofi has revealed that the ongoing debacle in the Philippines concerning its dengue vaccine Dengvaxia has not deterred it from …
Philippines’ launches legal action after Sanofi refuses to refund over dengue vaccine damages
February 5, 2018Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma
Sanofi has refused both requests from the Government of the Philippines to refund used doses of its Dengvaxia vaccine as …
Philippines’ Department of Health demands full refund of $70m Dengvaxia programme from Sanofi
January 30, 2018Manufacturing and Production, Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma
In the latest development in Sanofi’s Philippines dengue vaccine scandal, the nation’s Department of Health has demanded that the French …
Philippines’ FDA suspends Dengvaxia marketing, Sanofi responds
January 5, 2018Medical Communications, Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma
As the Dengvaxia scandal in the Philippines rolls into 2018, it emerges that the country’s Food and Drugs Administration has …
The race to find an effective dengue vaccine
December 4, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, biotech, dengue, drugs, pharma, pharmaceutical
Derek Wallace, Global Dengue Program Head at Takeda Vaccine Business Unit, discusses the recent Phase 2 results showing its vaccine …
Sanofi admits to dangers of its dengue vaccine
November 30, 2017Sales and Marketing Sanofi, biotech, dengue, drugs, pharma, pharmaceutical
After analysing six years’ worth of data on its dengue vaccine, Dengvaxia, Sanofi contacted health authorities to tell them that …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
